EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Lung Cancer in Special Populations

Matthew Triplette, Melinda C Aldrich

Seminars in Respiratory and Critical Care Medicine · 01.10.2025 · 46 (05) · 479-489

DOI: 10.1055/a-2657-9494 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Respiratory and Critical Care Medicine, erschienen am 01.10.2025. Verfasst von Matthew Triplette und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington. Hauptthemen laut MEDLINE: Lung Neoplasms, HIV Infections, Lung Diseases, Interstitial. Die Arbeit nennt 140 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is the leading cause of cancer deaths worldwide, claiming more lives than other age-related and screen-detectable cancers. Cigarette smoking remains the most important risk factor. However, despite common perceptions, risk is not related solely to cigarette smoking. Several vulnerable and special populations experience a disproportionate burden of lung cancer, often complicated by overlapping medical issues, diagnostic challenges, and treatment limitations. This review highlights four populations (people with HIV, persons who are immunocompromised, lung cancer in nonsmoking women, and individuals with interstitial lung disease [ILD]) who experience unique risks that impact early detection, diagnosis, and management of lung cancer. Three of these populations are frequently underrepresented in clinical trials, yet they may be at elevated risk due to chronic inflammation, immune dysregulation, or previous medical therapies. Individuals with HIV have a significantly increased incidence of lung cancer, often presenting at younger ages and with more advanced disease. Similarly, patients who are immunocompromised following organ or stem cell transplantation are at heightened risk due to prolonged immune dysfunction and prior exposures to toxic therapies. Individuals with ILD, especially idiopathic pulmonary fibrosis (IPF), have an increased risk of developing lung cancer, which is challenging to detect with imaging given architectural distortion and even more challenging to treat given limited pulmonary reserve. We also highlight women, as there has been a striking trend of rising incidence of lung cancer among women worldwide, particularly among those who have never smoked. The intersection of these risks with traditional lung cancer risk factors like tobacco smoking highlights a critical need for increased awareness, improved risk stratification, and adapted screening strategies that take these complexities into account. In this review, we explore the epidemiology, clinical presentation, and early detection and management challenges unique to each population, underscoring the necessity of precision approaches to support individualized care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsHIV InfectionsLung Diseases, InterstitialHumansRisk FactorsImmunocompromised HostFemaleEarly Detection of CancerMale

Autor:innen und Institutionen

  • Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.
  • Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington School of Medicine, Seattle, Washington.
  • Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.

Zitieren

APA

Triplette, M., & Aldrich, M. C. (2025). Lung Cancer in Special Populations. Seminars in Respiratory and Critical Care Medicine, 46(05), 479-489. https://doi.org/10.1055/a-2657-9494

Vancouver

Triplette M, Aldrich MC. Lung Cancer in Special Populations. Seminars in Respiratory and Critical Care Medicine. 2025;46(05):479-489. doi:10.1055/a-2657-9494

BibTeX
@article{Triplette2025,
  author = {Triplette, Matthew and Aldrich, Melinda C},
  title = {Lung Cancer in Special Populations},
  journal = {Seminars in Respiratory and Critical Care Medicine},
  year = {2025},
  volume = {46},
  number = {05},
  pages = {479--489},
  doi = {10.1055/a-2657-9494}
}
Kostenlos starten →